ロード中...
Improving Antibody‐Tubulysin Conjugates through Linker Chemistry and Site‐Specific Conjugation
Tubulysins have emerged in recent years as a compelling drug class for delivery to tumor cells via antibodies. The ability of this drug class to exert bystander activity while retaining potency against multidrug‐resistant cell lines differentiates them from other microtubule‐disrupting agents. Tubul...
保存先:
| 出版年: | ChemMedChem |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8048973/ https://ncbi.nlm.nih.gov/pubmed/33369163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.202000889 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|